Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.12
+0.44 (3.77%)
Apr 28, 2025, 4:08 PM HKT

HKG:2315 Statistics

Total Valuation

HKG:2315 has a market cap or net worth of HKD 4.66 billion. The enterprise value is 4.84 billion.

Market Cap 4.66B
Enterprise Value 4.84B

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date May 28, 2025
Ex-Dividend Date n/a

Share Statistics

HKG:2315 has 399.40 million shares outstanding. The number of shares has decreased by -0.08% in one year.

Current Share Class n/a
Shares Outstanding 399.40M
Shares Change (YoY) -0.08%
Shares Change (QoQ) -0.13%
Owned by Insiders (%) 13.87%
Owned by Institutions (%) 24.15%
Float 39.44M

Valuation Ratios

The trailing PE ratio is 130.24.

PE Ratio 130.24
Forward PE n/a
PS Ratio 4.47
PB Ratio 5.23
P/TBV Ratio 5.39
P/FCF Ratio 25.18
P/OCF Ratio 20.75
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.88, with an EV/FCF ratio of 26.12.

EV / Earnings 135.57
EV / Sales 4.64
EV / EBITDA 15.88
EV / EBIT 37.77
EV / FCF 26.12

Financial Position

The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.68.

Current Ratio 1.53
Quick Ratio 1.22
Debt / Equity 0.68
Debt / EBITDA 1.80
Debt / FCF 3.28
Interest Coverage 1.64

Financial Efficiency

Return on equity (ROE) is 4.12% and return on invested capital (ROIC) is 6.84%.

Return on Equity (ROE) 4.12%
Return on Assets (ROA) 3.86%
Return on Invested Capital (ROIC) 6.84%
Return on Capital Employed (ROCE) 7.99%
Revenue Per Employee 934,084
Profits Per Employee 31,956
Employee Count 1,117
Asset Turnover 0.40
Inventory Turnover 26.79

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +50.90% in the last 52 weeks. The beta is 0.06, so HKG:2315's price volatility has been lower than the market average.

Beta (5Y) 0.06
52-Week Price Change +50.90%
50-Day Moving Average 11.91
200-Day Moving Average 8.21
Relative Strength Index (RSI) 43.09
Average Volume (20 Days) 254,500

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2315 had revenue of HKD 1.04 billion and earned 35.69 million in profits. Earnings per share was 0.09.

Revenue 1.04B
Gross Profit 825.49M
Operating Income 159.80M
Pretax Income 45.70M
Net Income 35.69M
EBITDA 307.59M
EBIT 159.80M
Earnings Per Share (EPS) 0.09
Full Income Statement

Balance Sheet

The company has 437.48 million in cash and 606.87 million in debt, giving a net cash position of -169.39 million or -0.42 per share.

Cash & Cash Equivalents 437.48M
Total Debt 606.87M
Net Cash -169.39M
Net Cash Per Share -0.42
Equity (Book Value) 892.42M
Book Value Per Share 2.22
Working Capital 299.69M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 224.80 million and capital expenditures -39.51 million, giving a free cash flow of 185.29 million.

Operating Cash Flow 224.80M
Capital Expenditures -39.51M
Free Cash Flow 185.29M
FCF Per Share 0.46
Full Cash Flow Statement

Margins

Gross margin is 79.12%, with operating and profit margins of 15.32% and 3.42%.

Gross Margin 79.12%
Operating Margin 15.32%
Pretax Margin 4.38%
Profit Margin 3.42%
EBITDA Margin 29.48%
EBIT Margin 15.32%
FCF Margin 17.76%

Dividends & Yields

HKG:2315 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.08%
Shareholder Yield 0.08%
Earnings Yield 0.77%
FCF Yield 3.97%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:2315 has an Altman Z-Score of 0.83. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.83
Piotroski F-Score n/a